Journal Press India®

Journal of Futuristic Sciences and Applications

Barriers and Educational Interventions Influencing Adverse Drug Reaction Reporting among Community Pharmacists: Evidence from a Pharmacovigilance Study

Author Details ( * ) denotes Corresponding author

1. * Gujar Taranand Subhashrao, Research Scholar, Department of Pharmacy, Dr. Preeti Global University, Shivpuri, Madhya Pradesh, India (gujartaranandsubhashrao.pgu@gmail.com)
2. Gaurav Kant Saraogi, Professor, Department of Pharmacy, Dr. Preeti Global University, Shivpuri, Madhya Pradesh, India

Underreporting of adverse drug reactions (ADRs) remains one of the major limitations of pharmacovigilance systems worldwide. Community pharmacists play an important role in detecting and reporting ADRs because of their close interaction with patients. This study investigated the barriers affecting ADR reporting and evaluated the impact of educational interventions among community pharmacists participating in a pharmacovigilance program in Oman. A prospective interventional study was conducted among seven community pharmacies between March 2020 and March 2022. Pharmacists participated in a structured educational workshop on pharmacovigilance and ADR reporting procedures. Data regarding reporting barriers, pharmacist participation, and ADR reporting trends were collected and analyzed. The most common barriers identified were concerns regarding patient confidentiality (35.7%), competing clinical responsibilities (19.8%), lack of ADR reporting forms (15.2%), and uncertainty regarding reporting procedures (9.2%). Educational interventions significantly improved pharmacist awareness, confidence, and reporting participation. A total of 700 ADR reports were documented during the study period following implementation of the intervention program. The study highlights the importance of pharmacist education and standardized reporting systems in strengthening pharmacovigilance practices. Simplified reporting processes, regular training programs, and supportive healthcare policies are essential to improving ADR reporting rates in community pharmacy settings.

Keywords

Pharmacovigilance; ADR reporting; Community pharmacists; Educational intervention; Drug safety; Reporting barriers

  1. Rajakannan T, Mallayasamy S, Guddattu V, Kamath A, Vilakkthala R, Rao PG, Bairy LK. Cost of adverse drug reactions in a South Indian tertiary care teaching hospital. Journal of Clinical Pharmacology. 2012;52(4):559–565.
  2. D’Cruz S, Sachdev A, Tiwari P. Adverse drug reactions and their risk factors among Indian ambulatory elderly patients. Indian Journal of Medical Research. 2012;136(3):404.
  3. Inácio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: A systematic review. British Journal of Clinical Pharmacology. 2017;83:227–246.
  4. Kalaiselvan V, Prasad T, Bisht A, Singh S, Singh GN. Adverse drug reactions reporting culture in Pharmacovigilance Programme of India. Indian Journal of Medical Research. 2014;140:563–564.
  5. Pant J, Marwah H, Singh RM, Hazra S. An overview of the worldwide master key for pharmacovigilance and its role in India. Journal of Pharmacovigilance and Drug Research. 2021;2(2):19–26.
  6. Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study. Perspectives in Clinical Research. 2013;4(4):204.
  7. Ma’aji HU, Ilyas OS. Assessment of knowledge, attitude and practice of community pharmacists towards pharmaceutical care in Kaduna State, Nigeria. International Journal of Pharmacy Teaching and Practices. 2014;5(2):972–976.
  8. Olowofela A, Fourrier-Réglat A, Isah AO. Pharmacovigilance in Nigeria: An overview. Pharmaceutical Medicine. 2016;30:87–94.
  9. Hanafi S, Torkamandi H, Hayatshahi A, Gholami K, Javadi M. Knowledge, attitudes and practice of nurses regarding adverse drug reaction reporting. Iranian Journal of Nursing and Midwifery Research. 2012;17(1):21.
  10. Beninger P. Pharmacovigilance: An overview. Clinical Therapeutics. 2018;40(12):1991–2004.
  11. Jha N, Shankar PR, Bajracharya O, Gurung SB, Singh KK. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal. Australasian Medical Journal. 2012;5(5):268.
  12. Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Review of Clinical Pharmacology. 2015;8(4):449–460.
Abstract Views: 1
PDF Views: 3

Advanced Search

News/Events

Proceedings Title: I...

Title: International Conference on Southeast Asia and...

Book Title: Manageri...

Title: Managerial Effectiveness: Perspective, Insight...

💐Heartiest Congra...

Journal Press India team is delighted to extend warmest congratulation...

Birla Institute of M...

Birla Institute of Management Technology (BIMTECH), Greater Noida O...

Erasmus + Project AI...

Erasmus + Project AIDEdu in association with Vivekanand Education S...

Amity Institute of I...

Amity Institute of International Studies, Amity University, Noida in C...

PCETs S.B. Patil Ins...

PCETs, S. B. Patil Institute of Management, Pune Organising Interna...

Indukaka Ipcowala In...

Indukaka Ipcowala Institute of Management - Charotar University of Sci...

Department of MBA, K...

Department of MBA, KLS Gogte Institute of Technology, Belagavi Orga...

Dr. Moonje Institute...

C.H.M.E. Society's Dr. Moonje Institute of Management and Computer...

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.